Federal Register / Vol. 86, No. 156 / Tuesday, August 17, 2021 / Notices 46001 

professional organizations; federal 

agencies; and other stakeholders, 

including interested members of the 

public. Organizations are strongly 

encouraged to submit a single response 

that reflects the views of their 

organization and their membership as a 

whole. 

DATES: Comments must be received by 

11:59:59 p.m. (ET) on August 31, 2021 

to ensure consideration. 

ADDRESSES: All comments must be 

submitted electronically on the 

submission website, available at https:// 

rfi.grants.nih.gov/?s=60fef9beab

43000053007ed2. 

FOR FURTHER INFORMATION CONTACT: 

Please direct all inquiries to: Lisa 

Gansheroff, NIDDKstrategicplan@

nih.gov, 301–496–6623. 

SUPPLEMENTARY INFORMATION: This 

Notice is in accordance with the 21st 

Century Cures Act, NIH institutes are 

required to regularly update their 

strategic plans. The NIDDK’s ongoing 

Institute-wide strategic planning process 

will develop a broad vision for 

accelerating research into the causes, 

prevention, and treatment of diseases 

and conditions within the Institute’s 

mission. This overarching trans-NIDDK 

Strategic Plan will complement 

NIDDK’s disease-specific planning 

efforts. The Strategic Plan will have a 5- 

year time horizon but will also include 

planning for longer term efforts that 

could be initiated within this time 

frame. 

External input has been integral to the 

strategic planning process. NIDDK 

established a Working Group of Council, 

comprised of 44 external scientists and 

patient advocates, including a subset of 

the members of NIDDK’s Advisory 

Council and others with expertise across 

the range of NIDDK’s mission areas. The 

Institute also invited broad external 

input with a public RFI in 2020, and 

received valuable comments from 

organizations, individual researchers, 

people living with diseases in NIDDK’s 

mission, and others. Based on input 

from the Working Group, the previous 

RFI, and Council, the Institute has 

prepared a draft of the Strategic Plan; 

the draft will be available for public 

comment through August 31, 2021 via 

the new RFI at the link above. 

NIDDK is committed to empowering a 

multidisciplinary research community; 

engaging diverse stakeholders; and 

leveraging discoveries of connections 

among diseases across NIDDK’s mission 

to improve prevention, treatment, and 

health equity—pursuing pathways to 

health for all. This theme is addressed 

throughout the draft strategic plan. 

The draft Strategic Plan includes five 

major sections: 

• Advance understanding of 

biological pathways and environmental 

contributors to health and disease 

• Advance pivotal clinical studies 

and trials for prevention, treatment, and 

cures in diverse populations 

• Advance research to disseminate 

and implement evidence-based 

prevention strategies and treatments in 

clinics and community settings, to 

improve the health of all people, more 

rapidly and more effectively 

• Advance stakeholder engagement— 

including patients and other 

participants as true partners in research 

• Promote efficient and effective ways 

to serve as a trusted steward of public 

resources and support research for 

diseases across our mission 

NIDDK invites comments on the draft 

Strategic Plan from: The scientific 

research community; patients and 

caregivers; health care providers and 

health advocacy organizations; scientific 

and professional organizations; federal 

agencies; and other stakeholders, 

including interested members of the 

public. Organizations are strongly 

encouraged to submit a single response 

that reflects the views of their 

organization and membership as a 

whole. 

Responses to this RFI are voluntary 

and may be submitted anonymously. 

Please do not include any information 

that you do not wish to make public. 

Proprietary, classified, confidential, or 

sensitive information should not be 

included in your response. The 

Government will use the information 

submitted in response to this RFI at its 

discretion. Individual feedback will not 

be provided to any responder. The 

Government reserves the right to use 

any submitted information on public 

websites, in reports, in summaries of the 

state of the science, in any possible 

resultant solicitation(s), grant(s), or 

cooperative agreement(s), or in the 

development of future funding 

opportunity announcements. This RFI is 

for informational and planning purposes 

only and is not a solicitation for 

applications or an obligation on the part 

of the Government to provide support 

for any ideas identified in response to 

it. Please note that the Government will 

not pay for the preparation of any 

information submitted or for use of that 

information. NIDDK looks forward to 

your input and we hope that you will 

share this RFI with your colleagues. 

Dated: August 11, 2021. 

Bruce Tibor Roberts, 

Health Science Policy Analyst, Office of 

Scientific Program and Policy Analysis, 

National Institute of Diabetes and Digestive 

and Kidney Diseases, National Institutes of 

Health. 

[FR Doc. 2021–17535 Filed 8–16–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Clinical Trials and 

Comparative Effectiveness Studies. 

Date: August 23, 2021. 

Time: 10:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Shanta Rajaram, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Bethesda, MD 20892, 

(301) 435–6033, rajarams@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: August 11, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17559 Filed 8–16–21; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES